← Eichor
Condition: Ovarian Cancer Risk Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Ovarian Cancer Risk

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women
NA · 12 location(s) · M.D. Anderson Cancer Center · NCT00539162Exogenous Ketone Supplementation in Females with Polycystic Ovary Syndrome
NA · 1 location(s) · McGill University · NCT06155708TEAS Combined With Triple Antiemetic Drugs to Prevent PONV in High-Risk Patients
NA · 1 location(s) · Zhejiang University · NCT07480785A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ov
Phase N/A · 1 location(s) · Peking University Third Hospital · NCT07532434Liquid Biopsy Evaluation and Repository Development at Princess Margaret
Phase N/A · 1 location(s) · University Health Network, Toronto · NCT03702309Development and Validation of an Ovarian Cancer Risk Prediction Model for Family Members of Ovarian Cancer Probands
Phase N/A · 1 location(s) · Peking University Third Hospital · NCT07039552TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
NA · 66 location(s) · University Medical Center Nijmegen · NCT04294927PROADAPT-ovary/EWOC-2
NA · 11 location(s) · Hospices Civils de Lyon · NCT04284969Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery
Phase 2 · 1 location(s) · The Methodist Hospital Research Institute · NCT07050771Efbemalenograstim Alfa Injection for Ovarian or Cervical Cancer Receiving Chemotherapy Regimen
Phase 2 · 6 location(s) · Shandong University · NCT06251947ActiveGirls: Physical Activity, Hormone Health, and Diabetes Risk in Early Adolescence
NA · 1 location(s) · Massachusetts General Hospital · NCT07102797A Cohort Study of Hereditary Ovarian Cancer Risk Prediction Models and Pathogenesis Exploration
Phase N/A · 1 location(s) · Peking University Third Hospital · NCT06564428A Study of Biological, Genetic, and Constitutional Factors and Non-invasive Monitoring to Assess Personal Cancer Risks
Phase N/A · 1 location(s) · Fondazione del Piemonte per l'Oncologia · NCT07469709Ventral Hernias Following Cytoreductive Surgery : Incidence, Risk Factors and Surgical Management.
Phase N/A · 1 location(s) · Jules Bordet Institute · NCT07451483Familial Investigations of Childhood Cancer Predisposition
Phase N/A · 1 location(s) · St. Jude Children's Research Hospital · NCT03050268DAISy-PCOS Phenome Study - Dissecting Androgen Excess and Metabolic Dysfunction in Polycystic Ovary Syndrome
Phase N/A · 1 location(s) · Imperial College London · NCT03911297Cryopreservation of Ovarian Tissue
NA · 1 location(s) · Weill Medical College of Cornell University · NCT01558544The Gynecological Cancer Associated Thrombosis (GynCAT) Study
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06284343Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High
NA · 9 location(s) · M.D. Anderson Cancer Center · NCT05287451A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
NA · 549 location(s) · NRG Oncology · NCT04251052Disitamab Vedotin Combined With Platinum and Bevacizumab as First-Line and Maintenance Therapy for HER2-Expressing, HRD-
Phase 2 · 2 location(s) · Jiangsu Cancer Institute & Hospital · NCT07311577Surufatinib Combined With Carboplatin/Paclitaxel and Surufatinib Combined With Olaparib as First-line and Maintenance Th
Phase 2 · 1 location(s) · Anhui Provincial Cancer Hospital · NCT06437353Construction of a Multi-dimensional Risk Assessment System: a Clinical Study of Polycystic Ovary Syndrome Complicated Wi
Phase N/A · 1 location(s) · Guangdong Women and Children Hospital · NCT07571096Body Fat as Determinant of Female Gonadal Dysfunction
Phase N/A · 1 location(s) · Fundacion para la Investigacion Biomedica del Hospital Unive · NCT03841981Cancer Loyalty Card Study 2 (CLOCS-2)
Phase N/A · 1 location(s) · Imperial College London · NCT06447064CfDNA in Hereditary And High-risk Malignancies 2
Phase N/A · 8 location(s) · University Health Network, Toronto · NCT06726642PEPPI Study: Identification of Women at Risk for Placental Dysfunction
Phase N/A · 1 location(s) · Oulu University Hospital · NCT06115122OFS in Premenopausal Node+ Breast Cancer With Low Genomic Risk
Phase 4 · 2 location(s) · Gangnam Severance Hospital · NCT05333328Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
Phase N/A · 1 location(s) · MiraKind · NCT02253251Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ C
Phase 3 · 629 location(s) · Children's Oncology Group · NCT03067181
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.